Inverness Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.52M | Buy |
18,342
+1,241
| +7% | +$103K | 0.08% | 72 |
|
|
2022
Q2 | $1.63M | Sell |
17,101
-157
| -0.9% | -$14.9K | 0.09% | 63 |
|
|
2022
Q1 | $2.03M | Buy |
17,258
+8,537
| +98% | +$1.01M | 0.09% | 63 |
|
|
2021
Q4 | $1.13M | Sell |
8,721
-4,055
| -32% | -$525K | 0.04% | 80 |
|
|
2021
Q3 | $1.45M | Buy |
12,776
+5,511
| +76% | +$624K | 0.05% | 76 |
|
|
2021
Q2 | $752K | Buy |
+7,265
| New | +$752K | 0.03% | 96 |
|
|
2017
Q2 | – | Sell |
-7,755
| Closed | -$242K | – | 93 |
|
|
2017
Q1 | $242K | Sell |
7,755
-94,356
| -92% | -$2.94M | 0.02% | 84 |
|
|
2016
Q4 | $3.34M | Sell |
102,111
-259,629
| -72% | -$8.48M | 0.25% | 57 |
|
|
2016
Q3 | $14.5M | Sell |
361,740
-136,320
| -27% | -$5.48M | 1.14% | 34 |
|
|
2016
Q2 | $16.6M | Buy |
498,060
+58,275
| +13% | +$1.94M | 1.29% | 33 |
|
|
2016
Q1 | $12.9M | Buy |
+439,785
| New | +$12.9M | 1% | 36 |
|